Clinical Conversations

May 8th, 2022

Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD

The U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an editorial evaluation. This edition carries Brett’s advice on using the new guidelines in daily clinical practice. Brett’s JAMA editorial USPSTF […]

---

November 21st, 2015

Podcast 191: The prostate screening conundrum

[Running time: 13 minutes] The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find. Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and […]

---

January 15th, 2010

Podcast 70: Considering the USPSTF breast-screening guidelines with your patients

This is the podcast for January 15, 2010. We have an interview on the impact of the USPSTF guidelines with two clinicians who study the best ways to communicate clearly with patients. I think you’ll like it. You can reach me at jelia@jwatch.org or by calling 617-440-4374. If you like this podcast, there are many others in […]

---

November 22nd, 2009

Podcast 66: Niacin versus ezetimibe in the face of high cardiovascular risk — a conversation with the ARBITER 6-HALTS trialist Allen Taylor

One of the more intriguing pieces of research presented at the American Heart Association this week (and simultaneously released online in the New England Journal of Medicine) shows that extended-release niacin outperforms ezetimibe in high-risk patients. We talk with Dr. Allen J. Taylor, the study’s first author. Contact us at 1-617-440-4374 or write jelia@jwatch.org. This edition’s links: […]

---